Arcadia Biosciences (RKDA) Tops Q2 EPS by 78c
Tweet
Share
E-mailGet Alerts RKDA Hot Sheet
Join SI Premium – FREE
Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of $0.78. Revenue for the quarter came in at $1.31 million.
For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Allwyn AG (ALWN:GA) at Neutral
- JPMorgan Starts J&T Global Express (1519:HK) at Overweight
- JPMorgan Starts BridgeBio Oncology Therapeutics, In (BBOT) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
